Todd A. Davies
About
Todd A. Davies is a scholar working on Epidemiology, Pharmacology and Molecular Medicine.
According to data from OpenAlex, Todd A. Davies has authored 69 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 38 papers in Pharmacology and 37 papers in Molecular Medicine. Recurrent topics in Todd A. Davies's work include Pneumonia and Respiratory Infections (43 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Antibiotic Resistance in Bacteria (37 papers). Todd A. Davies is often cited by papers focused on Pneumonia and Respiratory Infections (43 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers) and Antibiotic Resistance in Bacteria (37 papers). Todd A. Davies collaborates with scholars based in United States, Switzerland and Netherlands. Todd A. Davies's co-authors include Peter C. Appelbaum, Michael R. Jacobs, Karen Bush, Wenchi Shang, Amelia Tait‐Kamradt, Glenn A. Pankuch, Joyce A. Sutcliffe, Robert K. Flamm, Kensuke Nagai and Bonifacio Dewasse and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
In The Last Decade
Todd A. Davies
68 papers receiving 2.7k citations
Peers
Todd A. Davies
Glenn A. Pankuch United States
Josefina Ayats Spain
Eui-Chong Kim South Korea
Alejandra Corso Argentina
D.F. Sahm United States
Ross Davidson Canada
Dee Shortridge United States
Kimberly A. Nichol Canada
Satowa Suzuki Japan
Deniz Gür Türkiye
Citations per year, relative to Todd A. Davies Todd A. Davies (= 1×)
peers
Glenn A. Pankuch
Countries citing papers authored by Todd A. Davies
Since
Specialization
Citations
This map shows the geographic impact of Todd A. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd A. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd A. Davies more than expected).
Fields of papers citing papers by Todd A. Davies
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Todd A. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd A. Davies. The network helps show where Todd A. Davies may publish in the future.
Co-authorship network of co-authors of Todd A. Davies
This figure shows the co-authorship network connecting the top 25 collaborators of Todd A. Davies. A scholar is included among the top collaborators of Todd A. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd A. Davies. Todd A. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fierro, Carlos, Michal Sarnecki, Bart Spiessens, et al.. (2024). A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI. npj Vaccines. 9(1). 106–106.
2.
Davies, Todd A., et al.. (2024). Patient compliance with medications, nasal douching, smoking cessation and long-term outcomes of surgical septorhinoplasty – a prospective series of 56 cases. Annals of The Royal College of Surgeons of England. 107(5). 369–372.
3.
Fierro, Carlos, Michal Sarnecki, Bart Spiessens, et al.. (2023). IMMUNOGENICITY OUTCOMES OF A RANDOMIZED, MULTICENTER, INTERVENTIONAL, FIRST-IN-HUMAN, PHASE 1/2A STUDY OF VAC52416 (EXPEC10V), A VACCINE CANDIDATE FOR THE PREVENTION OF INVASIVE ESCHERICHIA COLI DISEASE. International Journal of Infectious Diseases. 130. S114–S114.
4.
Castanheira, Mariana, Lalitagauri M. Deshpande, Anthony Costello, Todd A. Davies, & Ronald N. Jones. (2014). Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries. Journal of Antimicrobial Chemotherapy. 69(7). 1804–1814.
5.
Davies, Todd A., Robert K. Flamm, & A. Simon Lynch. (2012). Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone. International Journal of Antimicrobial Agents. 39(6). 534–538.
6.
Kiratisin, Pattarachai, Anan Chongthaleong, Thean Yen Tan, et al.. (2012). Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. International Journal of Antimicrobial Agents. 39(4). 311–316.
7.
Queenan, Anne Marie, Chris M. Pillar, Jennifer Deane, et al.. (2012). Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010. Diagnostic Microbiology and Infectious Disease. 73(3). 267–270.
8.
He, Wendy, Koné Kaniga, A. Simon Lynch, Robert K. Flamm, & Todd A. Davies. (2012). In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method. Diagnostic Microbiology and Infectious Disease. 74(4). 417–419.
9.
Davies, Todd A., Anne Marie Queenan, Brian J. Morrow, et al.. (2011). Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09. Journal of Antimicrobial Chemotherapy. 66(10). 2298–2307.
10.
Davies, Todd A., Wenchi Shang, Karen Amsler, et al.. (2009). Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials. International Journal of Antimicrobial Agents. 34(2). 166–168.
11.
Davies, Todd A.. (2008). Affinity of Ceftobiprole for Penicillin-Binding Protein 2b in Streptococcus pneumoniae (Spn) with Varying Penicillin Susceptibilities. 46th Annual Meeting.
12.
Davies, Todd A.. (2008). Sporadic Occurrences of Fluoroquinolone-Resistant Streptococcus pneumoniae in the United States: Longitudinal Analysis of Institutions from the New England and West South Central Regions During the TRUST 4-9 (2000-2005) Surveillance Studies. Postgraduate Medicine. 120(3 suppl 1). 25–32.
13.
Davies, Todd A., et al.. (2008). Effects of the 7-Valent Pneumococcal Conjugate Vaccine on U.S. Levofloxacin-Resistant Streptococcus pneumoniae. Microbial Drug Resistance. 14(3). 187–196.
14.
Davies, Todd A., et al.. (2006). Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999–2003). Journal of Antimicrobial Chemotherapy. 57(3). 437–442.
15.
Davies, Todd A.. (2003). Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). Journal of Antimicrobial Chemotherapy. 52(2). 168–175.
16.
Palavecino, Elizabeth, Clara Duran, Saralee Bajaksouzian, et al.. (2002). Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile. International Journal of Antimicrobial Agents. 20(2). 108–112.
17.
Davies, Todd A. & Raúl Goldschmidt. (2002). Screening of large numbers ofStreptococcus pneumoniaeisolates for mutations associated with fluoroquinolone resistance using an oligonucleotide probe assay. FEMS Microbiology Letters. 217(2). 219–224.
18.
Hoellman, Dianne B., et al.. (2001). Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms. Clinical Microbiology and Infection. 7(12). 703–705.
19.
Syrogiannopoulos, George A., Francesco Ronchetti, Ioanna N. Grivea, et al.. (2000). Mediterranean clone of penicillin-susceptible, multidrug-resistant serotype 6B Streptococcus pneumoniae in Greece, Italy and Israel. International Journal of Antimicrobial Agents. 16(3). 219–224.
20.
Davies, Todd A., Richard V. Goering, Marguerite Lovgren, et al.. (1999). Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagnostic Microbiology and Infectious Disease. 34(1). 7–12.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Glenn A. Pankuch Breakdown of academic impact, for papers by Josefina Ayats Breakdown of academic impact, for papers by Eui-Chong Kim Breakdown of academic impact, for papers by Alejandra Corso Breakdown of academic impact, for papers by D.F. Sahm Breakdown of academic impact, for papers by Ross Davidson Breakdown of academic impact, for papers by Dee Shortridge Breakdown of academic impact, for papers by Kimberly A. Nichol Breakdown of academic impact, for papers by Satowa Suzuki Breakdown of academic impact, for papers by Deniz Gür